Status:
UNKNOWN
Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery
Lead Sponsor:
Methodist Health System
Conditions:
Clinical Outcome of Pericardial Closure Using Gentrix
Eligibility:
All Genders
18-85 years
Brief Summary
A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix
Detailed Description
A descriptive, comparative project will be conducted utilizing a retrospective chart review on patients at Methodist Mansfield Medical Center(MMMC) undergoing cardiac surgery requiring pericardial rep...
Eligibility Criteria
Inclusion
- Must have undergone a Coronary Artery Bypass Grafting(CABG) or valve repair/replacement surgery requiring pericardial reconstruction.
- CABG or valve repair/replacement surgery must have been either elective or urgent status
Exclusion
- CABG or valve repair/replacement surgery classified as emergent status Surgery classified as redo-sternotomy
Key Trial Info
Start Date :
May 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 12 2024
Estimated Enrollment :
489 Patients enrolled
Trial Details
Trial ID
NCT06136182
Start Date
May 12 2023
End Date
May 12 2024
Last Update
November 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States, 75203
2
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203